Bayer and Evotec link to develop precision cardiology therapeutics
Pharmaceutical Technology
MAY 1, 2024
Bayer and Evotec have expanded collaboration to focus on the development of precision treatments for cardiovascular diseases (CVDs).
This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Pharmaceutical Technology
MAY 1, 2024
Bayer and Evotec have expanded collaboration to focus on the development of precision treatments for cardiovascular diseases (CVDs).
Medical Xpress
JANUARY 24, 2025
Researchers from Mass General Brigham and collaborating institutions have developed a non-invasive approach to manipulate cardiac tissue activity by using light to stimulate an innovative ink incorporated into bioprinted tissue. Their goal is to develop a technique that can be used to repair the heart.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
XTalks
SEPTEMBER 7, 2023
Los Angeles Lakers and Spain’s basketball legend Pau Gasol is investing in artificial intelligence (AI) company Idoven , which is developing an AI-powered cardiology service platform. Gasol joins Iker Casillas, Spain’s winning World Cup goalkeeper, as the second athlete to invest in the AI cardiology company.
pharmaphorum
APRIL 23, 2021
Amarin’s Vazkepa cardiology drug has been backed by the UK’s drugs regulator, following approval in Europe at the end of March. . The post UK regulator backs Amarin’s cardiology drug Vazkepa appeared first on. Icosapent ethyl also demonstrated a 26% relative risk reduction and a 3.6%
FDA Law Blog
NOVEMBER 10, 2024
Food and Drug Administration (FDA) plays a pivotal role in fostering the development of treatments for rare diseases through its Orphan Products Grants Program. Each year, FDA selects a limited number of clinical trials to fund to help sponsors pursue development of medical products for rare diseases and advance their field.
Medical Xpress
NOVEMBER 22, 2024
A team of artificial intelligence engineers, in collaboration with a team of physicians from Penn State Heart and Vascular Institute, is working to develop novel algorithms for point-of-care, in-house use and for technology licensing.
Outsourcing Pharma
DECEMBER 13, 2021
The pharmaceutical company currently has several promising treatments in development for gastroenterological, dermatological, and cardiological conditions.
Pharmaceutical Technology
JUNE 21, 2023
Participants treated with LODOCO had a 31% reduction in the overall risk of cardiovascular death, spontaneous myocardial infarction or ischaemic stroke when added to statins and other cardiology prevention therapies, compared to those treated with placebo.
Worldwide Clinical Trials
JANUARY 6, 2025
Tom Zhang, PhD, Chief Scientific Officer, Large Molecule Bioanalysis Revolutionizing Therapeutic Development with Cutting-Edge Bioanalysis Automation Cutting-edge advancements in bioanalysis (BioA) and drug R&D are reshaping the future of preventative and interventional care, but how do we harness these to their fullest potential?
Medical Xpress
JANUARY 25, 2023
Women with preeclampsia develop a higher likelihood of heart attack and stroke than their peers within just seven years of delivery, with risks remaining elevated more than 20 years later. The study of more than one million pregnant women is published today in the European Journal of Preventive Cardiology.
Medical Xpress
DECEMBER 20, 2022
Using machine learning and clinical data from electronic health records, researchers at the Icahn School of Medicine at Mount Sinai in New York constructed an in silico, or computer-derived, marker for coronary artery disease (CAD) to better measure clinically important characterizations of the disease.
Scienmag
NOVEMBER 13, 2020
Smidt Heart Institute Chair of Cardiology presents new findings at American Heart Association Scientific Sessions Credit: Photo by Cedars-Sinai LOS ANGELES (Nov.
Medical Xpress
FEBRUARY 24, 2023
People who used marijuana daily were found to be about one-third more likely to develop coronary artery disease (CAD) compared with people who have never used the drug, according to a study presented at the American College of Cardiology's Annual Scientific Session Together With the World Congress of Cardiology.
BioTech 365
DECEMBER 1, 2020
LUCA Science Announces Joint Research With Division of Cardiology, Field of Internal Medicine, Nagoya University Graduate School of Medicine on the Development of Mitochondrial Therapy for Myocardial Infarction (Cardiac Ischemic-reperfusion Injury) LUCA Science Announces Joint Research With Division of Cardiology, … Continue reading →
XTalks
OCTOBER 31, 2024
This includes new Phase III trial data for Kerendia (finerenone) in patients with heart failure that was presented recently at this year’s European Society of Cardiology (ESC) Congress 2024. Dr. Perkins has also led the development and implementation of innovative digital educational outreach campaigns for primary care physicians.
STAT News
MARCH 6, 2023
NEW ORLEANS — Aptly or paradoxically, thousands of the world’s leading cardiologists descended on the home of beignets, bouillabaisse, and beers sold to-go for a weekend-long dive into the latest developments in the science of keeping hearts beating healthily.
Medical Xpress
APRIL 18, 2023
Patients with severe COVID-19 requiring mechanical ventilation are 16 times more likely to develop ventricular tachycardia within six months compared to their peers without severe infection, according to research presented at EHRA 2023, a scientific congress of the European Society of Cardiology (ESC).
Scienmag
MAY 22, 2022
Madrid, Spain – 22 May 2022: Levels of alcohol consumption currently considered safe by some countries are linked with development of heart failure, according to research presented at Heart Failure 2022, a scientific congress of the European Society of Cardiology (ESC).1
Medical Xpress
FEBRUARY 24, 2023
People who became pregnant using assisted reproductive technologies were found to be over twice as likely to develop preeclampsia than those with traditional pregnancies, according to a study presented at the American College of Cardiology's Annual Scientific Session Together With the World Congress of Cardiology.
XTalks
APRIL 15, 2021
Experts from Servier and Genuity Science recently spoke on a webinar about using genomics data to drive drug development in heart failure and identify new targets for novel therapeutics. The reverse could also be true whereby the development of coronary artery disease may impact heart rate. HFrEF vs. HFpEF.
Rethinking Clinical Trials
DECEMBER 20, 2023
Further efforts are urgently needed to increase diversity in the cardiology workforce, which will improve clinical trial diversity and cardiovascular health for all. Approaches from the whole scientific community to tackle the inequality in workforce, trial leadership and trial participants have to be developed.
XTalks
NOVEMBER 26, 2024
BridgeBio’s leadership, including Neil Kumar, emphasizes the significance of Attruby’s approval as a cornerstone in their mission to develop therapies for genetic diseases. Patient advocacy groups, including the Amyloidosis Support Groups led by Muriel Finkel, highlight the transformative impact of Attruby on the lives of those with ATTR-CM.
Medical Xpress
FEBRUARY 15, 2023
Traffic noise may play an essential role in the development and deterioration of ischemic heart disease.
Medical Xpress
APRIL 27, 2023
A research team from Wake Forest University School of Medicine has developed an open-source, web-based application that allows users to generate customized hypertension statistics using National Health and Nutrition Examination Survey (NHANES) data.
Scienmag
APRIL 22, 2021
of the Division of Cardiovascular Medicine, Department of Internal Medicine) have developed an AI that uses multiple kinds of test data to predict the location of surplus pathways in the heart called ‘accessory pathways’, which cause the heart […].
pharmaphorum
DECEMBER 3, 2021
The Digital Health Academy – developed with pharma company Boehringer Ingelheim – is part of a drive to get digital health tools and apps used more routinely in the management of health conditions, according to ORCHA. More than third (37%) of those polled were also HCPs themselves.
pharmaphorum
FEBRUARY 1, 2022
A study has shown that a ‘smart’ stethoscope developed by US digital health company Eko can be used to screen people for heart failure in a few second during a standard physical examination. The device tested in the independent study combines a stethoscope used to listen to heart sounds with a single-lead electrocardiogram (ECG).
Scienmag
MARCH 19, 2022
Sophia Antipolis – 19 March 2022: Women are less likely to receive lifesaving treatment for cardiogenic shock than men, according to research presented today at ESC Acute CardioVascular Care 2022, a scientific congress of the European Society of Cardiology (ESC).1
STAT News
JANUARY 6, 2023
… Pfizer told employees it plans to pull back on early-stage research into treatments for rare diseases, including the development of new viral-based gene therapies , Barron’s reports. Among the assets on the chopping block is a gene therapy manufacturing facility in Durham, N.C.,
Medical Xpress
FEBRUARY 8, 2023
Rytis Maskeliūnas, a researcher at KTU's Faculty of Informatics, Lithuania together with an international team, has developed an app that will teach how to take care of a person who has suffered a stroke in a virtual environment. It is a condition that usually leaves the patient disabled, often requiring constant care.
Scienmag
JUNE 13, 2022
fold increased risk of developing hypertension 10 years post pregnancy compared to women who did not experience any hypertensive disorders of pregnancy (HDP), according to a study published today in the Journal of the American College of Cardiology. Women who experience gestational hypertension or preeclampsia have a 2.4-fold
Medical Xpress
NOVEMBER 25, 2022
The University of Twente and its partners are developing a smart wearable to automatically and reliably detect out-of-hospital cardiac arrest (OHCA), and to trigger an immediate emergency response.
Medical Xpress
JANUARY 4, 2023
In a new study by researchers from Mass General Brigham's founding members, Brigham and Women's Hospital and Massachusetts General Hospital, a team extensively investigated the immune response of 16 adolescents and young adults who developed myocarditis after receipt of the COVID mRNA vaccine.
Scienmag
OCTOBER 18, 2020
Beijing, China 19 Oct 2020: Elevated birth weight is linked with developing atrial fibrillation later in life, according to research presented at the 31st Great Wall International Congress of Cardiology (GW-ICC). Faculty from the European Society of Cardiology (ESC) will participate in joint scientific […].
Medical Xpress
FEBRUARY 1, 2023
Autism spectrum disorders may be associated with a higher risk for developing cardiometabolic diseases, according to a review published online Jan. 30 in JAMA Pediatrics.
Rethinking Clinical Trials
JULY 19, 2023
This was a cluster-randomized trial of 42 cardiology clinics across the U.S., The cardiology clinics were randomized to one of two groups. It is essential to scale this intervention across cardiology practices in order to improve the quality of care being delivered more broadly to ensure the implementation of these trial results.
Scienmag
JULY 22, 2021
New USDA-NIFA funding brings together research, academics, and Extension to improve knowledge, access, and self-monitoring skills for hypertension management Credit: Edwin Remsberg, University of Maryland To address the significant health burden of hypertension (characterized by consistently high blood pressure), the University of Maryland (UMD) was (..)
Rethinking Clinical Trials
FEBRUARY 14, 2024
DCP developed an EHR-based workflows and integrated workflows within the local VA primary care setting. DCP developed 3 electronic workflows with 6 major configurations including applications needed outside of the EHR system. DCP developed a patient tracking tool that nurses could use to make sure patients got through each step.
Medical Xpress
DECEMBER 16, 2022
Myocardial infarction is an ischemic disease in which a coronary artery supplying blood to the heart muscle is stenotic or obstructed, resulting in cardiac tissue necrosis. Due to the irreversible loss of cardiomyocytes, damaged heart tissue cannot be naturally regenerated.
Velocity Clinical Research
MARCH 19, 2024
The summit focused on Velocity’s Diabetes + Obesity, MASH, Vaccine, Cardiology, and Women’s Health CARE Councils, along with a few areas in development.
Rethinking Clinical Trials
APRIL 13, 2023
The context and stakeholder input have been key in developing and implementing nudges. Discussion Themes – In the last few years, there has been great reception to the value of behavioral science and implementation science in the field of cardiology.
BioPharma Reporter
MAY 23, 2023
Neurimmune has announced that primary results of its phase 1 proof-of-concept study of NI006, a recombinant human antibody to deplete amyloid deposits in ATTR cardiomyopathy, have been presented in Prague at Heart Failure 2023, a scientific congress of the European Society of Cardiology (ESC), and published in The New England Journal of Medicine.
Scienmag
JUNE 27, 2021
Sophia Antipolis – 28 June 2021: A study in more than 200,000 individuals has found that patients with heart failure are more likely to develop cancer compared to their peers without heart failure.
The Pharma Data
OCTOBER 31, 2020
With that in mind, the American College of Cardiology came up with some safety recommendations in May, which have now been revised. How many athletes with COVID-19 develop heart problems isn’t known, but the group said those who have moderate to severe coronavirus symptoms should be screened. 26 in JAMA Cardiology.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content